UEM EDGENTA BERHAD Integrated Annual Report 2025 384 NOTES TO THE FINANCIAL STATEMENTS For the year ended 31 December 2025 Name of Companies Country of incorporation Issued and paid-up share capital RM Effective proportion of ownership interest Principal activities 2025 % 2024 % Joint Venture of KOA: DuaSatu FZ L.L.C United Arab Emirates AED 3,000,000 24 - Investment in commercial enterprises & management, and patent & intellectual property rights management (a) Audited by member firms of Ernst & Young Global in respective countries (b) Audited by firms other than Ernst & Young PLT or any member firms of Ernst & Young Global (c) Edgenta Mediserve Sdn. Bhd. is 43% owned by UEM Edgenta Berhad and 57% owned by Edgenta Healthcare Management Sdn. Bhd. (d) Opus Al-Dauliyyah L.L.C. is 95% owned by Opus International (M) Berhad and 5% owned by Opus Management Sdn. Bhd. (e) Classified as disposal group held for sale in the previous financial year (Note 28) (f) Notwithstanding Edgenta PROPEL Berhad’s (“EPB”) effective shareholding of less than 50% in Edgenta PROPEL (Sarawak) Sdn. Bhd. (“EPS”), the Group does have the substantive rights and power to direct the relevant activities of EPS and the ability to use the power to significantly affect its returns as stipulated in the shareholder’s agreement. Therefore, EPS is consolidated in the Group’s consolidated financial statements. (g) In the previous financial year, Opus International (M) Sdn. Bhd. (“OIM”) entered into Share Sale Agreement to acquire the remaining 70% ownership in Opus Consultants (M) Sdn. Bhd. (“OCM”). The transaction was finalised on 12 December 2024, upon which OCM transitioned from being an associate to becoming a subsidiary of the Group on the same date. The step-up acquisition in OCM had resulted in the recognition of gain on deemed disposal of associate of RM1,000 at the consolidated financial statements, as disclosed in Note 19. The acquisition gain of RM9.5 million arose due to OCM’s advantageous negotiating position. 47. SUBSIDIARIES, JOINT VENTURES AND ASSOCIATES (CONTD.) Details of subsidiaries, joint ventures and associates are as follows: (contd.)
RkJQdWJsaXNoZXIy NDgzMzc=